Cargando…

Antiretroviral Therapy for HIV-Associated Cutaneous Kaposi's Sarcoma: Clinical, HIV-Related, and Sociodemographic Predictors of Outcome

Kaposi's sarcoma (KS) is an AIDS-defining malignancy that can improve or worsen with antiretroviral therapy (ART). We aimed at identifying clinical, HIV-related, and sociodemographic factors associated with either progression or nonprogression (regression or stable disease) of ART-treated HIV-a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ngalamika, Owen, Munsaka, Sody, Lidenge, Salum J., West, John T., Wood, Charles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc., publishers 2021
Materias:	Outcomes Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112720/ https://www.ncbi.nlm.nih.gov/pubmed/33386064 http://dx.doi.org/10.1089/aid.2020.0099

Ejemplares similares

Outcome markers of ART-treated HIV+ patients with early stage Kaposi’s sarcoma
por: Ngalamika, Owen, et al.
Publicado: (2020)

Cells of the Innate and Adaptive Immune Systems in Kaposi's Sarcoma
por: Ngalamika, Owen, et al.
Publicado: (2020)

Lack of CD8(+) T-cell co-localization with Kaposi’s sarcoma-associated herpesvirus infected cells in Kaposi’s sarcoma tumors
por: Lidenge, Salum J., et al.
Publicado: (2020)

SARS-CoV-2-Specific T Cell Immunity in HIV-Associated Kaposi Sarcoma Patients in Zambia
por: Ngalamika, Owen, et al.
Publicado: (2022)

Comparative transcriptome analysis of endemic and epidemic Kaposi’s sarcoma (KS) lesions and the secondary role of HIV-1 in KS pathogenesis
por: Lidenge, Salum J., et al.
Publicado: (2020)

RNA-Seq of Kaposi’s sarcoma reveals alterations in glucose and lipid metabolism
por: Tso, For Yue, et al.
Publicado: (2018)

Viral and Immunological Analytes are Poor Predictors of the Clinical Treatment Response in Kaposi’s Sarcoma Patients
por: Lidenge, Salum J., et al.
Publicado: (2020)

Co-infection and co-localization of Kaposi sarcoma-associated herpesvirus and Epstein-Barr virus in HIV-associated Kaposi sarcoma: a case report
por: Julius, Peter, et al.
Publicado: (2023)

Viral and immunological markers of HIV-associated Kaposi sarcoma recurrence
por: Ngalamika, Owen, et al.
Publicado: (2021)

HIV-Associated Cutaneous Kaposi's Sarcoma
por: Alluhaybi, Abdulrahman F, et al.
Publicado: (2021)

The Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) gH/gL Complex Is the Predominant Neutralizing Antigenic Determinant in KSHV-Infected Individuals
por: Mortazavi, Yasaman, et al.
Publicado: (2020)

Upregulation of Cell Surface Glycoproteins in Correlation with KSHV LANA in the Kaposi Sarcoma Tumor Microenvironment
por: Privatt, Sara R., et al.
Publicado: (2023)

Admitted AIDS-associated Kaposi sarcoma patients: Indications for admission and predictors of mortality
por: Vally, Faheema, et al.
Publicado: (2020)

Elevated iNOS and 3′-nitrotyrosine in Kaposi's Sarcoma tumors and mouse model
por: Vladimirova, Olga, et al.
Publicado: (2023)

Immune correlates of Mycobacterium Tuberculosis patients in Zambia stratified by HIV serostatus and level of immunity-a cross-sectional analytical laboratory based study
por: Lungu, Patrick, et al.
Publicado: (2022)

Antibody epitope profiling of the KSHV LANA protein using VirScan
por: Bennett, Sydney J., et al.
Publicado: (2022)

The malignant potential of HIV-associated Kaposi sarcoma
por: Wood, Neil H, et al.
Publicado: (2008)

Pulmonary, ocular and cutaneous Kaposi sarcoma in a HIV-infected patient
por: Ionică, Mihaela, et al.
Publicado: (2014)

Colesional cutaneous talaromycosis (penicilliosis) and Kaposi sarcoma in an HIV‐infected patient
por: Lai, Shau‐Kong, et al.
Publicado: (2021)

Antiretroviral therapy and Kaposi’s sarcoma trends and outcomes among adults with HIV in Latin America
por: Castilho, Jessica L, et al.
Publicado: (2021)

Pulmonary Kaposi Sarcoma: an uncommon presentation in HIV heterosexual female on antiretroviral therpay
por: Bhattarai, Bikash, et al.
Publicado: (2020)

Immune activation and arterial stiffness in lean adults with HIV on antiretroviral therapy
por: Kaluba, Longa, et al.
Publicado: (2021)

SARS-CoV-2-specific T cell and humoral immunity in individuals with and without HIV in an African population: a prospective cohort study
por: Ngalamika, Owen, et al.
Publicado: (2023)

Factors Associated with Treatment Outcomes Among Children and Adolescents Living with HIV Receiving Antiretroviral Therapy in Central Kenya
por: McLigeyo, Angela, et al.
Publicado: (2022)

Predictors of Linkage to Care for Newly Diagnosed HIV-Positive Adults
por: Aaron, Erika, et al.
Publicado: (2015)

Association of Abnormal Liver Function Parameters with HIV Serostatus and CD4 Count in Antiretroviral-Naive Rwandan Women
por: Dusingize, Jean Claude, et al.
Publicado: (2015)

The Persistence of HIV Diversity, Transcription, and Nef Protein in Kaposi’s Sarcoma Tumors during Antiretroviral Therapy
por: Nolan, David J., et al.
Publicado: (2022)

Kaposi's sarcoma as a presenting manifestation of HIV
por: Mehta, Sharad, et al.
Publicado: (2011)

Characteristics of Kaposi sarcoma in HIV-infected patients
por: Jipa, Raluca, et al.
Publicado: (2014)

Kaposi Sarcoma as Initial Presentation of HIV Infection
por: Warpe, Bhushan Malhari
Publicado: (2014)

Eyelid Kaposi Sarcoma in an HIV-negative Patient
por: Abalo-Lojo, José Manuel, et al.
Publicado: (2018)

Recent advances in HIV-associated Kaposi sarcoma
por: Dalla Pria, Alessia, et al.
Publicado: (2019)

Histological variants of cutaneous Kaposi sarcoma
por: Grayson, Wayne, et al.
Publicado: (2008)

Colesional Cutaneous Kaposi Sarcoma and Cryptococcosis
por: Ismail, Abdullah, et al.
Publicado: (2021)

Antimicrobial resistance of Neisseria gonorrhoeae isolated from patients attending sexually transmitted infection clinics in Urban Hospitals, Lusaka, Zambia
por: Sarenje, Kelvin L., et al.
Publicado: (2022)

The prognostic significance of facial lymphoedema in HIV-seropositive subjects with Kaposi sarcoma
por: Feller, L, et al.
Publicado: (2008)

Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy
por: Franceschi, S, et al.
Publicado: (2008)

Multicentric Castleman’s Disease and Kaposi’s Sarcoma in a HIV-Positive Patient on Highly Active Antiretroviral Therapy
por: Ortega, Lauro, et al.
Publicado: (2014)

Kaposi sarcoma incidence in the Swiss HIV cohort study before and after highly active antiretroviral therapy
por: Franceschi, S, et al.
Publicado: (2009)

High prevalence of pre-existing serological cross-reactivity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in sub-Saharan Africa
por: Tso, For Yue, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_47q4eaqhlvvsrdnjb7r45i0f1k